Our Advisers

Bruce Booth, a partner at life science and technology investment firm Atlas Venture; Martin D. Burke, an organic chemist at the University of Illinois, Urbana-Champaign; Douglas Crawford, a managing director at bioscience investment firm Mission Bay Capital; Paula T. Hammond, a chemical engineer at Massachusetts Institute of Technology; Laura L. Kiessling, a biochemist at the University of Wisconsin, Madison; Jay Lichter, a biotech investor at Avalon Ventures; Craig W. Lindsley, a medicinal chemist at Vanderbilt University; Timothy M. Swager, a materials and analytical chemist at MIT; Christopher Welch, a process and analytical chemist at Merck & Co.; and Helma Wennemers, an organic chemist at the Swiss Federal Institute of Technology (ETH), Zurich.